Revolutionizing Breast Cancer Treatment: Anixa Biosciences and Cleveland Clinic Unveil Promising Results from Phase 1 Study at SITC Annual Meeting

Data continues positive trend as additional patients are enrolled in 3 cohorts Vaccine was safe and well tolerated by participants in all 3 cohorts Protocol defined immune responses were exhibited in over 70% of patients A Phase 2 study evaluating the vaccine in the neoadjuvant setting is planned to commence in 2025 SAN JOSE, Calif.,…

Read More

Unveiling the Future: A Recap of Lifetime Brands Inc.’s Q3 2024 Earnings Call

Lifetime Brands, Inc. (NASDAQ:LCUT) Q3 2024 Earnings Conference Call Company Participants: Rory Rumore – Director at MZ Group Rob Kay – Chief Executive Officer Larry Winoker – Chief Financial Officer Conference Call Participants: Anthony Lebiedzinski – Sidoti & Company Madison Callinan – Canaccord Genuity Operator: Good morning, ladies and gentlemen, and welcome to Lifetime Brand’s…

Read More

Uncovering the Insights: A Recap of Information Services Group Inc.’s Q3 2024 Earnings Call

Information Services Group, Inc. (NASDAQ:III) Q3 2024 Earnings Conference Call Company Participants Barry Holt – Senior Communications Executive, ISG Michael Connors – Chairman and Chief Executive Officer Michael Sherrick – Executive Vice President and Chief Financial Officer Conference Call Participants Joe Gomes – Noble Capital Markets Vincent Colicchio – Barrington Research Marc Riddick – Sidoti…

Read More

Get the Scoop: Wise PLC’s Half-Year Results for FY 2025 Earnings Call – A Playful and Relatable Recap!

Wise plc Half Year Results for FY 2025 Conference Call Playful Insights into Wise plc’s Latest Earnings Report Gather ’round, folks! It’s that time of year again when we dive deep into the financial world of Wise plc. With their Half Year Results for FY 2025 recently announced, our favorite finance enthusiasts Martin Adams, Kristo…

Read More

Attention all Stockholders: M&A Madness! Investigating the AlloVir Inc. Merger – Don’t Miss Out!

Welcome to the M&A Class Action Firm’s Blog! Investigating the AlloVir Inc. Merger with Kalaris Therapeutics Hey there, fellow shareholders and curious minds! Have you heard the news about the proposed merger between AlloVir Inc. (NASDAQ: ALVR) and Kalaris Therapeutics? If not, don’t worry – we’ve got you covered! First things first, let’s talk about…

Read More

Revolutionizing Pharmacy Compliance: Pearson Medical Technologies Launches m-Print Bar Code Labeling Software v4 for DSCSA Compliance

Pearson Medical Technologies Releases m:Print® Bar Code Labeling Software Version 4 Introduction ALEXANDRIA, La., Nov. 08, 2024 (GLOBE NEWSWIRE) — Pearson Medical Technologies is thrilled to announce the international release of m:Print® Bar Code Labeling Software Version 4. This powerful upgrade of their pharmacy barcode label printing software is set to revolutionize the medication repackaging…

Read More